Delivery Order SPE2DB22D3016-SPE2DB24FBGU4

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S. The contract has a ceiling value of $1,419.28 and is structured as a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract as a child...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.33 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, with a ceiling value of $1,374.33. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with a value of $1,163.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, and falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the parent company Cencora, Inc. (doing business as Amerisourcebergen). This IDC...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, with a ceiling value of $1,314.30. The contract is for firm fixed price delivery and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $4,938.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product. The contract has a completion date of March 15, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,258.37, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S medical products. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,588.01 firm-fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, with a completion date of January 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $15,978.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product, and has an ultimate completion date of October 30, 2024. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.88 delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a specialized medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This single-award...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBGU4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S. The contract is a firm fixed-price delivery order with a ceiling value of $1,228.51 and a completion date of September 16, 2024. This order is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, and there is no mention of any major subcontractors. The DLA is a defense agency that supports the supply chain needs of the U.S. military, and this contract award is likely part of the agency's efforts to ensure the availability of essential pharmaceutical products for military treatment facilities and other government healthcare programs.

Generated 12/13/24, 9:23 AM